Becton Dickinson (BDX) Net Equity Issued and Repurchased (2017)

Becton Dickinson's (BDX) quarterly Net Equity Issued and Repurchased came in at $4.8 billion in Q2 2017.

Becton Dickinson (BDX) Net Equity Issued and Repurchased (2017) Analysis & Trends

Becton Dickinson (BDX) has 1 years of Net Equity Issued and Repurchased data on file, last reported at $4.8 billion in Q2 2017.

On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $4.8 billion in Q2 2017; TTM through Sep 2020 was $4.8 billion, a 0.0% change from a year earlier, with the FY2020 full-year figure at $2.9 billion, changed N/A from the prior year.
Net Equity Issued and Repurchased for Q2 2017 stood at $4.8 billion.
Over the last five years, Net Equity Issued and Repurchased for BDX reached as high as $4.8 billion in Q2 2017 and fell as low as $4.8 billion in Q2 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Equity Issued and Repurchased (Qtr)
1	Alcon	32,734,969.19 Bn	32,734,967.53 Bn	1.53 Bn	-
2	Intuitive Surgical	117.50 Bn	112.41 Bn	1.96 Bn	-
3	Becton Dickinson	42.93 Bn	42.11 Bn	2.15 Bn	-
4	Medline	30.82 Bn	36.66 Bn	1.84 Bn	-
5	Resmed	27.90 Bn	26.23 Bn	890.98 Mn	7.43 Mn
6	West Pharmaceutical Services	26.76 Bn	26.23 Bn	329.20 Mn	-
7	Cooper Companies	15.30 Bn	15.16 Bn	735.40 Mn	-
8	Solventum	13.46 Bn	12.90 Bn	1.10 Bn	-
9	Align Technology	12.02 Bn	10.96 Bn	736.59 Mn	11.72 Mn
10	Baxter International	11.17 Bn	9.12 Bn	891.00 Mn	-

Download Data

Date	Value
Jun 30, 2017	4.80 Bn
Jun 30, 2017	4.80 Bn